It affects cognitive abilities, including memory, concentration, and decision-making skills, which can lead to decreased performance at work or school
Standard clinical dose escalation The FDA-approved Mounjaro (brand tirzepatide) follows this schedule: Weeks 1-4: 2.5 mg once weekly (starting dose, allows GI adaptation) Weeks 5-8: 5 mg once weekly (first therapeutic dose increase) Weeks 9-12: 7.5 mg once weekly (if tolerated and additional effect needed) Weeks 13-16: 10 mg once weekly (continued escalation) Weeks 17-20: 12.5 mg once weekly (approaching maximum) Week 21+: 15 mg once weekly (maximum approved dose) Each dose is maintained for at least four weeks before escalation
For questions, you can reach us at 1-647-576-2076
Safety Profile and Who Should Avoid Dulaglutide Dulaglutide is generally well-tolerated, with nausea, vomiting, and diarrhea being the most common side effects, typically mild and transient
Link NEJM
Period and blood sugar: Hormone fluctuations during your menstrual cycle directly impact how your body processes glucose, leading to varied energy levels